Add to my selection

NERLYNX

Medicine - Posted on May 30 2023

Active substance (DCI)

nératinib

history (2)

5/24/23

NERLYNX (neratinib) - Breast cancer

Inclusion. Key points Unfavourable opinion for reimbursement “in the extended adjuvant treatment of adult patients with earl...

CAV :
54321

icône flèche
6/24/20

NERLYNX

First assessment. Unfavourable opinion for reimbursement in the extended adjuvant treatment of adult patients with early-sta...

CAV :
54321

icône flèche

Technical information

ATC code

L01EH02

Manufacturer

PIERRE FABRE MÉDICAMENT

Presentation

NERLYNX 40 mg, comprimé pelliculé
1 flacon de 180 comprimés pelliculés (CIP : 34009 301 944 9 2)

All our publications